연세대학교 산학협력단;INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY;MEDICINAL BIOCONVERGENCE RESEARCH CENTER;재단법인 의약바이오컨버젼스연구단
发明人:
KIM, Sunghoon,김성훈,KIM, Jong Hyun,김종현,HAN, Gyoonhee,한균희,HAN, Jung Min,한정민,LEE, Chulho,이철호
申请号：
KRKR2019/006873
公开号：
WO2019/235879A1
申请日:
2019.06.07
申请国别(地区):
KR
年份:
2019
代理人:
摘要：
The present invention relates to a composition for preventing or treating cancer, containing a novel mTOR inhibitor and, more specifically, to a pharmaceutical composition for preventing or treating cancer, containing, as an active ingredient, a novel inhibitor that is represented by chemical formula 1 and exhibits an mTORC1 inhibitory activity.La présente invention concerne une composition pour prévenir ou traiter un cancer, contenant un nouvel inhibiteur de mTOR et, plus particulièrement, une composition pharmaceutique pour prévenir ou traiter le cancer, contenant, en tant que principe actif, un nouvel inhibiteur qui est représenté par la formule chimique 1 et qui présente une activité inhibitrice de mTORC1.본 발명은 신규 mTOR 저해제를 포함하는 암 예방 또는 치료용 조성물에 관한 것으로, 보다 상세하게는 mTORC1 저해 활성을 나타내는 화학식 1로 표시되는 신규 화합물을 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물에 관한 것이다.
